Next Article in Journal
Prevention and Treatment of Bone Metastases in Breast Cancer
Next Article in Special Issue
Bone Targeted Therapies for Bone Metastasis in Breast Cancer
Previous Article in Journal
Engraftment Outcomes after HPC Co-Culture with Mesenchymal Stromal Cells and Osteoblasts
Previous Article in Special Issue
Where Do Bone-Targeted Agents RANK in Breast Cancer Treatment?
J. Clin. Med. 2013, 2(3), 136-150; doi:10.3390/jcm2030136
Review

Mechanisms of Metastatic Tumor Dormancy

 and *
Received: 26 July 2013; in revised form: 20 August 2013 / Accepted: 10 September 2013 / Published: 23 September 2013
(This article belongs to the Special Issue Prevention and Treatment of Bone Metastases from Breast Cancer)
View Full-Text   |   Download PDF [322 KB, uploaded 23 September 2013]   |   Browse Figure
Abstract: Tumor metastasis can occur years after an apparent cure due to a phenomenon known as metastatic tumor dormancy; in which tumor masses or individual tumor cells are growth restricted for extended periods of time. This period of dormancy is induced and maintained by several mechanisms, including: (1) Tumor microenvironment factors such as cytokine expression, immunosurveillance and angiogenesis; (2) Metastasis suppressor gene activity; and (3) Cancer therapeutics. Disseminated tumor cells (DTC) are the key cells that result in dormant tumors. However, many challenges exist towards isolating DTCs for mechanistic studies. The main DTC that may represent the dormant cell is the cancer stem cells (CSC) as they have a slow proliferation rate. In addition to limited knowledge regarding induction of tumor dormancy, there are large gaps in knowledge regarding how tumors escape from dormancy. Emerging research into cancer stem cells, immunotherapy, and metastasis suppressor genes, may lead to new approaches for targeted anti-metastatic therapy to prevent dormancy escape. Overall, an enhanced understanding of tumor dormancy is critical for better targeting and treatment of patients to prevent cancer recurrence.
Keywords: dormancy; tumor mass dormancy; tumor cell dormancy dormancy; tumor mass dormancy; tumor cell dormancy
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Osisami, M.; Keller, E.T. Mechanisms of Metastatic Tumor Dormancy. J. Clin. Med. 2013, 2, 136-150.

AMA Style

Osisami M, Keller ET. Mechanisms of Metastatic Tumor Dormancy. Journal of Clinical Medicine. 2013; 2(3):136-150.

Chicago/Turabian Style

Osisami, Mary; Keller, Evan T. 2013. "Mechanisms of Metastatic Tumor Dormancy." J. Clin. Med. 2, no. 3: 136-150.


J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert